Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1041 of 5804
-
New cell therapy aims to boost hearing restoration in cochlear implant patients
Disease control Not yet recruitingRinri Therapeutics is conducting a clinical trial of a new cell therapy called Rincell-1. Rincell-1 is being developed to treat adults with neural hearing loss, either age related hearing loss or auditory neuropathy, who also meet criteria for a cochlear implant. The goals of thi…
Phase: PHASE1, PHASE2 • Sponsor: Rinri Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
New Pill-and-Infusion combo aims to keep liver cancer in check
Disease control Not yet recruitingThis research study is for people who were treated with tremelimumab and durvalumab for advanced liver cancer and who are currently receiving durvalumab. Participants in this study will receive a drug called zanzalintinib. They will also continue receiving durvalumab. Studies hav…
Phase: PHASE2 • Sponsor: Amit Mahipal • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Can your local pharmacy help stop HIV and STIs? new study aims to find out.
Prevention Not yet recruitingThis proposed 3-arm randomized study will compare different pharmacy based approaches that include HIV prevention medication (PrEP and PEP), routine STI testing, and preventive antibiotic (doxycycline) for STIs. The study will assess how well these services can be implemented, ho…
Phase: NA • Sponsor: University of Washington • Aim: Prevention
Last updated Jun 27, 2026 09:00 UTC
-
Could a protein on blood cancer cells lead to a new treatment?
Knowledge-focused Not yet recruitingThe surface protein IL-1RAP, expressed by leukemic blast cells, represents a target of interest for patients with acute myeloid leukemia (AML). Its restricted and specific expression on leukemic cells makes it a promising target for chimeric antigen receptor T-cell (CAR-T cell) …
Phase: NA • Sponsor: University Hospital, Grenoble • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:11 UTC
-
Simple mouthpiece could ease heart strain in sleep apnea patients
Disease control Not yet recruitingHeart failure with reduced ejection fraction (HFrEF) is a serious condition that limits daily activities and often leads to hospital stays and early death. Many patients with HFrEF also have obstructive sleep apnea (OSA), a common but often undiagnosed condition where breathing r…
Phase: NA • Sponsor: National University Hospital, Singapore • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Weight-Loss drug may curb alcohol cravings in fatty liver patients
Disease control Not yet recruitingThere is evidence that alcoholic beverage consumption significantly interacts with food energy intake. Furthermore, there is accumulating evidence showing independent, combined, and modifying effects of alcohol and metabolic factors on the onset and progression of chronic liver d…
Phase: NA • Sponsor: Insel Gruppe AG, University Hospital Bern • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
AI eye doctor: new study aims to spot Blindness-Causing diseases
Diagnosis Not yet recruitingThis is a retrospective, multicenter, observational study designed to develop and validate an artificial intelligence (AI) system capable of detecting and classifying major ophthalmic diseases (glaucoma, cataract, diabetic retinopathy, and other retinal pathologies) in the Costa …
Sponsor: Marisse Masis-Solano • Aim: Diagnosis
Last updated Jun 27, 2026 12:01 UTC
-
Can ancient herbs stop colon polyps from coming back?
Prevention Not yet recruitingThis multicenter, randomized, double-blind, placebo-controlled trial aims to evaluate the efficacy and safety of Jianpi Lishi Jiedu Granules in preventing postoperative recurrence of colorectal advanced adenoma. A total of 376 patients aged 18-80 years with endoscopically resecte…
Phase: PHASE3 • Sponsor: Nanjing First Hospital, Nanjing Medical University • Aim: Prevention
Last updated Jun 27, 2026 12:02 UTC
-
New scan duo could spot stomach cancer more clearly
Diagnosis Not yet recruitingThe purpose of this study was to evaluate the diagnostic efficacy and prognostic value of 18F-FAPI PET/CT combined with multiparameter MRI in gastric cancer.
Sponsor: First Affiliated Hospital of Zhejiang University • Aim: Diagnosis
Last updated Jun 27, 2026 12:04 UTC
-
Robotic scope could biopsy and burn lung nodules in one go
Disease control Not yet recruitingThis is a prospective, single-arm, open-label clinical study. The primary study objective is to evaluate the feasibility of synchronous biopsy and radiofrequency ablation for pulmonary nodules under robotic-assisted bronchoscopy.
Phase: NA • Sponsor: Shanghai Chest Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
New study pits elagolix against birth control pills for endometriosis pain relief
Symptom relief ENROLLING_BY_INVITATIONThis study is designed to provide direct evidence on the relative effectiveness and safety of Elagolix versus OCPs, helping physicians make more tailored treatment decisions.
Phase: PHASE4 • Sponsor: Pak Emirates Military Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 12:07 UTC
-
Robotic surgery plus daily swallowing therapy aims to keep head and neck cancer patients eating and speaking normally
Symptom relief Recruiting nowThis study aims to evaluate whether an intensive and personalized speech, swallowing, and voice rehabilitation (SSVR) program can help preserve swallowing function in patients with head and neck cancer undergoing minimally invasive robotic-assisted extended "Sistrunk" surgery (RE…
Phase: NA • Sponsor: Christian Simon • Aim: Symptom relief
Last updated Jun 27, 2026 12:31 UTC
-
New cell therapy aims to supercharge Kids' immune cells after transplant
Disease control Not yet recruitingA first-in-class adoptive immunotherapy we called ThINKK, for Therapeutic Inducers of Natural Killer (NK) cell Killing, have been designed for use after hematopoietic stem cell transplantation (HSCT), where the proper stimulation of graft-derived NK cells has been shown to preven…
Phase: PHASE1 • Sponsor: Michel Duval • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
New pill targets Hard-to-Treat cancers in early human trial
Disease control Not yet recruitingThe goal of this study is to learn if KQB368 works to treat advanced solid malignancies in adults. The study will also learn about the safety of KQB368. The main questions the study aims to answer are: * What is the safe dose of KQB368 as a monotherapy? * Does KQB368 decrease th…
Phase: PHASE1 • Sponsor: Kumquat Biosciences Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Poop pills for cancer wasting? new trial hopes gut bugs boost appetite
Symptom relief Not yet recruitingThis project is a prospective, multicenter, single-arm, phase II clinical study aimed at evaluating the efficacy and safety of fecal microbiota transplantation (FMT) in treating advanced tumor cachexia.
Phase: PHASE2 • Sponsor: Hua Jiang • Aim: Symptom relief
Last updated Jun 27, 2026 12:08 UTC
-
New drug cocktail aims to tackle tough blood cancers
Disease control Not yet recruitingThe study will evaluate NX-5948 (bexobrutideg) in combination with venetoclax with or without an anti-CD20 antibody (rituximab or obinutuzumab) in second-line or higher (2L+) relapsed/refractory (R/R) or first-line (1L) chronic lymphocytic leukemia (CLL)/small lymphocytic lymphom…
Phase: PHASE1, PHASE2 • Sponsor: Nurix Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
Own skin cell spray could speed burn healing and cut scarring
Disease control Not yet recruitingThis study is a prospective, multicenter, real-world observational study. It aims to evaluate the effectiveness and safety of a combined therapy-autologous epidermal cell suspension followed by biological dressing (porcine xenograft) coverage-for wound repair after dermabrasion o…
Sponsor: First Affiliated Hospital, Sun Yat-Sen University • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
Radiation-Free hope: study tests if surgery alone is enough for rare nasal cancer
Disease control Not yet recruitingBackground: Sinonasal adenoid cystic carcinoma (ACC) is a rare type of cancer that starts in the nasal cavity or sinuses. Although surgery can remove the tumor, doctors often recommend radiation therapy after surgery to reduce the chance of the cancer coming back. However, radia…
Sponsor: Eye & ENT Hospital of Fudan University • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
3D movies could be a fun new treatment for lazy eye in children
Symptom relief Not yet recruitingAmblyopia is a common childhood visual disorder that affects vision in one eye and can also impair depth perception (stereopsis). Standard treatment typically involves occlusion therapy (patching the stronger eye), which improves visual acuity but often does not fully restore bin…
Phase: NA • Sponsor: Universitat Politècnica de Catalunya • Aim: Symptom relief
Last updated Jun 27, 2026 12:29 UTC
-
Umbilical cord stem cells tested for shoulder injury
Disease control Not yet recruitingThe purpose of this study is to evaluate umbilical cord-derived mesenchymal stem cell injectables for the regeneration of partial-thickness rotator cuff tears
Phase: NA • Sponsor: Kyoung Hwan Koh • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC